1. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA
   Shushan Zhang et al, 2023, Journal of Nanobiotechnology CrossRef
2. Autophagy in liver diseases
   Elias Kouroumalis et al, 2021, World Journal of Hepatology CrossRef
3. An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
   Yusheng Guo et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
4. Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
   Chunying Xiao et al, 2023, Frontiers in Pharmacology CrossRef
5. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway
   Yongchuan Zhang et al, 2020, BioMed Research International CrossRef
6. Radiofrequency ablation triggers the migration of hepatocellular carcinoma cells by suppressing miR-148a-5p
   Haicun Wang et al, 2020, Biological Chemistry CrossRef
7. Specific Inhibitor of Matrix Metalloproteinase Decreases Tumor Invasiveness After Radiofrequency Ablation in Liver Tumor Animal Model
   An-Na Jiang et al, 2020, Frontiers in Oncology CrossRef
8. Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
   Shilun Wu et al, 2022, Frontiers in Oncology CrossRef